Director Dealings

Transactions

Dealing dateCompany / TickerName / TitleSharesPer shareDeal size
Purchase07 Aug 2026Braveheart Bio, Inc.BRVE:NMQChristopher A. ViehbacherChairman of the Board83,33318.00
USD
1.50m USD
Purchase07 Aug 2026Braveheart Bio, Inc.BRVE:NMQDavid MalekDirector4,16618.00
USD
74.99k USD
Purchase07 Aug 2026Braveheart Bio, Inc.BRVE:NMQDavid Charles LubnerIndependent Director55,55518.00
USD
999.99k USD
Sale07 Aug 2026ACNB CorpACNB:NAQD. Arthur SeibelDirector1,50064.35
USD
96.53k USD
Purchase07 Aug 2026Savannah Energy PLCSAVE:LSEAndrew Allister KnottExecutive Director,Chief Executive Officer128,550,0000.068
GBP
8.74m GBP
Sale07 Aug 2026Barclays PLCBARC:LSEAnna CrossExecutive Director,Finance Director461,5885.21
GBP
2.41m GBP
Purchase07 Aug 2026Braveheart Bio, Inc.BRVE:NMQTravis MurdochDirector, President and Chief Executive Officer83,33318.00
USD
1.50m USD
Sale06 Aug 2026Dime Community Bancshares, Inc.DCOM:NYQRaymond A. NielsenIndependent Director1,80041.73
USD
75.11k USD
Purchase06 Aug 2026Bed Bath & Beyond IncBBBY:NYQRobert Jacob ShapiroIndependent Director3,0004.51
USD
13.53k USD
Sale06 Aug 2026Samsara Inc.IOT:NYQJohn BicketExecutive Vice President, Chief Technology Officer and Director57,26737.89
USD
2.17m USD
Purchase06 Aug 2026BrightView Holdings, Inc.BV:NYQWilliam L. CornogIndependent Director40,00011.25
USD
450.00k USD
Purchase06 Aug 2026BrightView Holdings, Inc.BV:NYQWilliam L. CornogIndependent Director10,00011.24
USD
112.40k USD
Purchase06 Aug 2026Aware IncAWRE:NMQAjay K. AmlaniDirector, Chief Executive Officer and President391.26
USD
49.00 USD
Purchase06 Aug 2026Bed Bath & Beyond IncBBBY:NYQJoseph J. TabaccoIndependent Director20,0004.57
USD
91.40k USD
Sale06 Aug 2026BancFirst CorpBANF:NSQDavid E. RainboltNon-Executive Chairman of the Board3,000115.00
USD
345.00k USD
26076 total results
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.